Hanover - Delayed Quote EUR

Vertex Pharmaceuticals Inc (VX1.HA)

439.60

-4.10

(-0.92%)

At close: May 2 at 5:25:29 PM GMT+2

5 Growth Stocks to Buy in May and Go Away

The Trade Desk's share price has been clobbered this year, but its prospects are bright. Vertex Pharmaceuticals' impressive momentum should continue with new drugs on the market and a promising pipeline. The premise is that stock market returns are often lower between May and October than from November to April.

Motley Fool 3 hours ago

NVDA

AMZN

META
Vertex Pharmaceuticals (VRTX) Outperforms Broader Market: What You Need to Know

Vertex Pharmaceuticals (VRTX) reachead $509.47 at the closing of the latest trading day, reflecting a +1.19% change compared to its last close.

Zacks 3 days ago

VRTX

^GSPC
What Analyst Projections for Key Metrics Reveal About Vertex (VRTX) Q1 Earnings

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Vertex (VRTX), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2025.

Zacks 3 days ago

VRTX
Analysts Estimate Entrada Therapeutics, Inc. (TRDA) to Report a Decline in Earnings: What to Look Out for

Entrada Therapeutics (TRDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks 4 days ago

TRDA

VRTX
Vertex Gears Up to Report Q1 Earnings: Is a Beat in the Cards?

On VRTX's first-quarter earnings call, investors are likely to focus on the launch preparation for Alyftrek (vanza triple) and Journavx (suzetrigine).

Zacks 5 days ago

VRTX
Vertex Pharmaceuticals (VRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Vertex (VRTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks 5 days ago

VRTX
My 5 Top Stocks to Buy Right Now in This Highly Volatile Market

The major market indexes are behaving like a frantic yo-yo, swinging up or down depending on the latest tariff- or Fed-related news from the White House. You can still find attractive stocks despite all of the turbulence. Here are my five top stocks to buy right now in this highly volatile market.

Motley Fool 6 days ago

VRTX

EPD

PFE
Wall Street’s New Tariff Safe Haven: High-Tax Biotech Stocks

As tariffs loom over the sector, biotechs with U.S.-based manufacturing and intellectual property are soothing investor concerns.

The Wall Street Journal 7 days ago

VRTX

MRK

GILD
CRISPR Therapeutics to Report Q1 Earnings: What's in the Cards?

On CRSP's first-quarter 2025 earnings call, investors will likely focus on the sales numbers of its new gene therapy, Casgevy.

Zacks 8 days ago

CRSP

VRTX
Vertex Pharmaceuticals (VRTX) Advances But Underperforms Market: Key Facts

Vertex Pharmaceuticals (VRTX) closed at $492.47 in the latest trading session, marking a +0.01% move from the prior day.

Zacks 9 days ago

VRTX
Top 20 biopharmas’ market cap rises 6% in Q1 2025 amid tariff headwinds

The biopharmaceutical industry is positioned for continued recovery, driven by recent FDA approvals and billion-dollar strategic collaborations.

Pharmaceutical Technology 9 days ago

GLDAF

VRTX
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

Vertex (VRTX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks 10 days ago

VRTX
Why Vertex Pharmaceuticals Was Such a Healthy Stock on Tuesday

Vertex Pharmaceuticals (NASDAQ: VRTX) had a fine Tuesday on the stock exchange. One of these two impactful publications was issued by Swiss bank UBS analyst Eliana Merle. The second of the pair was part of a broader dive into the current state of pharmaceutical stocks by investment bank Cantor Fitzgerald.

Motley Fool 11 days ago

VRTX

^GSPC
3 Relatively Safe Healthcare Growth Stocks You Can Buy and Hold

When the stock market is highly volatile, many investors flock to assets that offer stability but dismal growth prospects. Three Fool.com contributors believe they've identified relatively safe growth stocks in the healthcare sector that you can buy and hold. Here's why they picked Amgen (NASDAQ: AMGN), Eli Lilly (NYSE: LLY), and Vertex Pharmaceuticals (NASDAQ: VRTX).

Motley Fool 11 days ago

VRTX

LLY

AMGN
Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Zacks 11 days ago

VRTX

CAH
Fed Chairman Jerome Powell Warns Trump's Tariffs Could Cause Stagflation: 3 Stocks to Buy and Hold if He's Right

President Trump isn't a fan of Fed Chairman Jerome Powell, despite nominating Powell to replace Janet Yellen in 2017. Trump recently called Powell a "major loser" on a social media post and demanded that he lower interest rates immediately. On the other hand, Powell doesn't appear to be a fan of Trump's economic policies, either.

Motley Fool 12 days ago

VRTX

KR

D
Vertex Pharmaceuticals (NasdaqGS:VRTX) Faces UK Patent Lawsuit Over Groundbreaking CASGEVY Therapy

Vertex Pharmaceuticals (NasdaqGS:VRTX) saw its share price rise by approximately 14% in the last quarter, a significant move considering the broader market's recent 1% decline. The company's legal challenges, such as the patent infringement lawsuit filed by ToolGen Inc., could have influenced investor sentiment, highlighting the competitive tensions in the biotech sector. Furthermore, the recent European label expansion for KAFTRIO and advancements in its Type 1 diabetes portfolio may have...

Simply Wall St. 12 days ago

VRTX
Don't Try to Time the Market: These 2 Stocks Are Buys Regardless of What Happens Next

Equity markets have been seesawing for the past two weeks. Stocks fell hard after President Donald Trump announced his tariff plans, then bounced back big once he said he would pause expanded tariffs on imported goods from most countries for 90 days. It's hard to predict which way major indexes will move next, but amid all this volatility, it helps to buy shares of companies that are likely to perform well in the long run.

Motley Fool 16 days ago

VRTX

VEEV
Stock Market Whiplash: 3 Growth Stocks That Are No-Brainer Buys on the Bounce

On one hand, it's understandable that Amazon's (NASDAQ: AMZN) share price fell as much as 29% below its previous high during the recent market sell-off. After all, the company's e-commerce revenue could be at risk if tariffs lead to an economic decline that causes consumer spending to sink. On the other hand, I'd argue that Amazon is more insulated from a faltering economy than meets the eye.

Motley Fool 19 days ago

AMZN

VRTX

META
April 2025's Stocks That May Be Priced Below Their Estimated Value

As the U.S. stock market navigates a period of heightened volatility, with major indexes experiencing significant fluctuations amid tariff discussions and economic uncertainties, investors are keenly observing opportunities that may arise from these turbulent conditions. In such an environment, identifying stocks that appear to be undervalued can offer potential value, as they might be trading below their estimated worth due to broader market pressures rather than company-specific issues.

Simply Wall St. 19 days ago

SE

VRT

VRTX

Performance Overview

Return	VX1.HA	S&P 500 (^GSPC)
YTD	+12.96%	-3.31%
1-Year	+17.56%	+12.29%
3-Year	+69.04%	+36.85%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Vertex Pharmaceuticals Inc (VX1.HA)

5 Growth Stocks to Buy in May and Go Away

Vertex Pharmaceuticals (VRTX) Outperforms Broader Market: What You Need to Know

What Analyst Projections for Key Metrics Reveal About Vertex (VRTX) Q1 Earnings

Analysts Estimate Entrada Therapeutics, Inc. (TRDA) to Report a Decline in Earnings: What to Look Out for

Vertex Gears Up to Report Q1 Earnings: Is a Beat in the Cards?

Vertex Pharmaceuticals (VRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

My 5 Top Stocks to Buy Right Now in This Highly Volatile Market

Wall Street’s New Tariff Safe Haven: High-Tax Biotech Stocks

CRISPR Therapeutics to Report Q1 Earnings: What's in the Cards?

Vertex Pharmaceuticals (VRTX) Advances But Underperforms Market: Key Facts

Top 20 biopharmas’ market cap rises 6% in Q1 2025 amid tariff headwinds

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

Why Vertex Pharmaceuticals Was Such a Healthy Stock on Tuesday

3 Relatively Safe Healthcare Growth Stocks You Can Buy and Hold

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Fed Chairman Jerome Powell Warns Trump's Tariffs Could Cause Stagflation: 3 Stocks to Buy and Hold if He's Right

Vertex Pharmaceuticals (NasdaqGS:VRTX) Faces UK Patent Lawsuit Over Groundbreaking CASGEVY Therapy

Don't Try to Time the Market: These 2 Stocks Are Buys Regardless of What Happens Next

Stock Market Whiplash: 3 Growth Stocks That Are No-Brainer Buys on the Bounce

April 2025's Stocks That May Be Priced Below Their Estimated Value

Performance Overview